Crossmark

Safety of SGLT-2 inhibitors in patients with glycogen storage disease type Ib and their efficacy in treating disease-associated digestive symptoms and disorders

Crossref DOI link: https://doi.org/10.1007/s00592-025-02627-8

Published Online: 2026-01-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Ziqiu

Sun, Zheng

Li, Ge

Bu, Huaien https://orcid.org/0000-0001-6616-2959
License Information

Text and Data Mining valid from 2026-01-28

Version of Record valid from 2026-01-28
More Information

Article History

Received: 23 September 2025

Accepted: 17 November 2025

First Online: 28 January 2026

Declarations

:

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below